Polycystic kidney disease 2

Polycystic Kidney Disease 2 (PKD2) is a genetic disorder characterized by the growth of numerous cysts in the kidneys. It is one of the forms of Polycystic Kidney Disease (PKD), the other being Polycystic Kidney Disease 1 (PKD1). PKD2 is generally considered to be a milder form of PKD, with symptoms often appearing later in life compared to PKD1. This article focuses on the genetic, clinical, and therapeutic aspects of PKD2.

Genetics

PKD2 is caused by mutations in the PKD2 gene, which encodes for polycystin-2, a protein that is involved in calcium channeling within kidney cells. The PKD2 gene is located on chromosome 4. Unlike PKD1, which accounts for the majority of PKD cases, PKD2 is responsible for approximately 15% to 20% of cases. The disease is inherited in an autosomal dominant manner, meaning that a mutation in one of the two copies of the gene is sufficient to cause the disorder.

Symptoms

The symptoms of PKD2 typically develop later in life, usually between the ages of 30 and 40. However, the severity and onset of symptoms can vary widely among individuals. Common symptoms include:

• Hypertension (high blood pressure)
• Pain in the back and sides
• Blood in the urine (Hematuria)
• Frequent kidney infections
• Kidney stones
• Kidney failure

Diagnosis

Diagnosis of PKD2 often involves a combination of family history, genetic testing, and imaging studies. Ultrasound is the most common imaging technique used to detect cysts in the kidneys, but MRI (Magnetic Resonance Imaging) and CT scans (Computed Tomography scans) can provide more detailed images.

Treatment

There is no cure for PKD2, but treatment focuses on managing symptoms and preventing complications. Treatment options may include:

• Medication to control blood pressure
• Pain management
• Treatment for urinary tract infections
• Dialysis or kidney transplant in cases of kidney failure

Prognosis

The prognosis for individuals with PKD2 is generally better than for those with PKD1. Many people with PKD2 maintain a good quality of life and normal kidney function well into old age. However, the risk of kidney failure increases with age.

Research

Research into PKD2 is ongoing, with studies focusing on understanding the genetic mechanisms of the disease and developing targeted therapies. Gene therapy and new medications that can slow the progression of kidney damage are areas of particular interest.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian